#Germany #Bio-Techne #Düsseldorf #Leo System

Bio-Techne Corporation Expands Reach with New Centre in Düsseldorf

Bio-Techne Corporation, known for its innovative life science solutions, has announced an exciting development: the opening of a new Customer Experience Centre in Düsseldorf, Germany. This strategic move aims to enhance customer service and support the company’s growth in the European, Middle Eastern, and African (EMEA) regions.

Details of the New Centre

The new Customer Experience Centre is slated to launch in the summer of 2026. It will feature a cutting-edge Demonstration Laboratory that showcases Bio-Techne's entire instrument portfolio. This includes the newly-released Leo™ System, which is a game-changer for bioanalytical workflows as it automates western blot assays, and the best-in-class spatial biology platform, COMET™. The COMET™ platform stands out as the only fully-automated, high-throughput hyperplex tool designed for superior tissue profiling capabilities.

Dr. Peter Schuessler, Vice President of EMEA at Bio-Techne, emphasized the significance of this initiative: “Our new Customer Experience Centre will complement our existing facility in the UK. This expansion will provide more customers in the region hands-on experiences with our distinctive instruments, showcasing how our solutions can not only accelerate their scientific endeavors but also expedite the market introduction of next-generation therapies.”

Strategic Location

Düsseldorf was chosen as the site for this new facility due to its vibrant life sciences sector and its advantageous proximity to the Benelux region. This strategic location positions Bio-Techne to better serve clients from multiple European markets, ensuring seamless access and enhanced customer interaction.

The establishment of this new centre is part of Bio-Techne's long-term growth strategy, especially vital in tapping into Germany's robust market. Additionally, the expanded capacity will facilitate the growth of Bio-Techne's customer-facing teams in the EMEA region, propelling the company’s regional initiatives further.

About Bio-Techne

Bio-Techne Corporation (NASDAQ: TECH) is a global leader in life sciences, providing cutting-edge tools and bioactive reagents for researchers and clinical diagnostics. The company’s commitment is rooted in aiding scientific exploration into biological processes and advancing the understanding of various diseases. With an extensive portfolio that includes hundreds of thousands of products, Bio-Techne reported impressive net sales of approximately $1.2 billion for the fiscal year of 2024 and employs around 3,100 individuals globally.

For more insights into Bio-Techne and its product offerings, visit Bio-Techne’s official website or follow the company’s updates on social media platforms like Facebook, LinkedIn, Twitter, and YouTube.

In closing, this new Customer Experience Centre signifies a significant leap for Bio-Techne in its mission to continuously support the evolving needs of its customers across the EMEA region. Bio-Techne remains committed to pushing the boundaries of science by providing cutting-edge resources and an environment conducive to innovation and growth.